The latest price target for BioHarvest Sciences (NASDAQ:BHST) was reported by Maxim Group on December 18, 2024. The analyst firm set a price target for $12.00 expecting BHST to rise to within 12 months (a possible 97.69% upside). 3 analyst firms have reported ratings in the last year.

The latest analyst rating for BioHarvest Sciences (NASDAQ:BHST) was provided by Maxim Group, and BioHarvest Sciences initiated their buy rating.

There is no last upgrade for BioHarvest Sciences

There is no last downgrade for BioHarvest Sciences.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of BioHarvest Sciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for BioHarvest Sciences was filed on December 18, 2024 so you should expect the next rating to be made available sometime around December 18, 2025.

While ratings are subjective and will change, the latest BioHarvest Sciences (BHST) rating was a initiated with a price target of $0.00 to $12.00. The current price BioHarvest Sciences (BHST) is trading at is $6.07, which is within the analyst’s predicted range.